A miniaturized ad MPS platform for high-throughput drug screening
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00001
- Awardee
-
Neucyte Inc. UEI X263NRWQNLL6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $500,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20231 · Posted Jul 20, 2022
- Contract value 100% obligated
- $500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Mountain View, CA 94043, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $500,000 |
About this award
This $500,000 firm fixed price contract was awarded by the National Institutes of Health National Institute on Aging to Neucyte Inc. to conduct research and development in support of a Phase I Small Business Innovation Research project. The contract calls for Neucyte to develop a miniaturized automated drug screening platform to support the NIH's mission of advancing biomedical research on aging. The work will be performed in Mountain View, California over a one year period beginning in November 2023. The award was made under a total small business set-aside solicitation issued by NIH and the Centers for Disease Control and Prevention seeking innovative proposals to address over 125 topic areas across both agencies, including cancer treatment, infectious diseases, and public health.
Quick answers
Who was awarded contract 75N95024C00001?
75N95024C00001 was awarded to Neucyte Inc. by National Institute on Drug Abuse (National Institutes of Health) on November 15, 2023.
How much is contract 75N95024C00001 worth?
The government has obligated $500,000 on 75N95024C00001.
Which agency awarded contract 75N95024C00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024C00001, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95024C00001 competed?
The extent of competition for 75N95024C00001 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award